-
Nordex secured its first New Zealand order as Mercury contracted 40 N133/4.8 turbines for the 192 MW Puke Kapo Hau wind farm, along with a 30 year service deal.
-
The long term service contract gives Nordex a potential recurring revenue stream while anchoring its entry into a new onshore wind market.
-
We will now look at how Nordex's long term New Zealand service agreement could reshape the broader investment narrative for the business.
Scan beyond Nordex and this Mercury contract by reviewing hand-picked peers in the global renewables build out via the 42 power grid technology and infrastructure stocks
Nordex Investment Narrative Recap
To own Nordex, you need to be comfortable with a wind turbine manufacturer that still leans heavily on Europe but is trying to widen its footprint and deepen higher margin services. The Mercury deal in New Zealand adds a long dated contract, although it is small compared with an €8.0b plus revenue base, so it does not radically change the operational picture.
The near term focus still sits on converting a large order backlog into projects with solid pricing and clean execution, while keeping service margins healthy. Key risk remains geographic concentration in Europe and industry wide price pressure, and this contract only modestly reduces that exposure in the short run.
The most relevant backdrop to the Mercury win is Nordex keeping its 2026 sales outlook unchanged at €8.2b to €9.0b. That guide shows management is framing New Zealand as part of a broader build out of projects and services rather than a swing factor for near term revenue.
For you as a shareholder, the link between this guidance and the Mercury contract is execution. Nordex is signalling confidence that it can handle a global project mix while maintaining its earnings profile, yet still faces sector wide competition, policy risk in key European markets, and ongoing legacy warranty cash outflows that can pressure free cash flow if they persist.
Nordex's current analyst narrative points to revenues of €10.4b and earnings of €731.5m by 2029, based on 9.0% yearly revenue growth and an earnings increase of about €330.7m from €400.8m today.
Uncover why Nordex's fair value indicates a 37% potential upside to its current price that could narrow quickly.
Exploring Other Perspectives
Some of the most optimistic Nordex analysts focus on global diversification as a catalyst and already pencilled in about €11.7b of revenue and €892.7m of earnings by 2029 before this New Zealand contract existed. You can treat this Mercury deal as a possible test case for that story and explore how far opinions can differ.
Explore 3 other Nordex fair value estimates , including one that suggests as much as 64% upside from the current price.
The Verdict Is Yours
Don't just follow the ticker; dig into the data and build a conviction that's truly your own.
-
A great starting point for your Nordex research is our analysis highlighting 4 key rewards that could impact your investment decision.
-
See our latest analysis for Nordex. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Nordex's overall financial health at a glance.
Looking For More Ideas Beyond Nordex?
If you want to pressure test your Nordex view against other opportunities, use the Simply Wall St Screener to line it up next to companies with very different risk and return profiles.
-
For investors who want potential upside but still care about balance sheet strength, start with this curated list of solid balance sheet and fundamentals (207 results) to see which businesses pair financial resilience with fundamental support.
-
If you are hunting for mispriced opportunities with quality traits, compare Nordex to a 195 high quality undervalued stocks that screens for both strong cash generation and sensible valuations.
-
Income focused readers can benchmark Nordex against a 224 dividend fortresses that highlights companies offering higher yields with an emphasis on stability.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NDX1.DE .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
